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Who solved the protein folding problem? 
Manfred J Sippl
For the third time, techniques for the prediction of three-
dimensional structures of proteins were critically assessed
in a worldwide blind test. Steady progress is undeniable.
How did this happen and what are the implications?
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In December 1998, a crowd of predictors, assessors and
onlookers assembled in Asilomar, California to quarrel
over the current state of affairs in protein structure predic-
tion. One hundred teams sacrificed their 98 summer vaca-
tion to compute a total of 3800 structural models for 43
protein sequences, the structures of which were deter-
mined in parallel by X-ray crystallography and nuclear
magnetic resonance (NMR) laboratories. The heat contin-
ued in December when predictions were inspected, dis-
sected and searched for traces of structural similarity to
target folds and when teams and techniques were judged
by rigorous assessors.
The details of this third critical assessment of techniques
for protein structure prediction, or CASP for short, fill a
forthcoming special issue of Proteins: Structure, Function
and Genetics and summaries and comments on CASP3
appear in many journals. There is no need to repeat these
observations here, and so we are free to dedicate this pre-
cious space to a reflection on protein structure prediction,
the CASP idea, its life cycle, an overall view of the results
obtained and their significance for structural biology.
The protein folding problem fascinates the scientist, the
educated layman and the entrepreneur. For some, the
folding protein is the most incredible message they ever
saw — a message that turns itself into the thing it
describes. For others, it is the philosopher’s stone that
transforms cryptic sequences into fortunes. Whatever the
reason, considerable efforts have been spent on cracking
the folding code and the past 30 years are filled with
success stories. Nevertheless, for a long time no practical
solution has emerged.
The essential goal of protein structure theory is the com-
putational determination, or ‘prediction’, of protein struc-
tures from amino acid sequences ahead of experiment. To
demonstrate the value of a method the correct answer
must be unknown in the calculation, but has to be avail-
able for evaluation. A serious researcher will exert self-
control and simulate this situation, but in practice this is
hard to achieve. Methods are often knowledge-based,
relying to some degree on experimental data, and
although a particular simulation environment might be
accepted by some as unbiased, it could be rejected as
biased by others.
Another issue is how to measure success in structure pre-
diction. The targets are experimental structures deter-
mined by X-ray analysis and nowadays also by NMR.
Neglecting variations in resolution and quality as well as
problems of flexibility and dynamics, these targets are the
‘gold standard’. But then, how far is the arrow from the
bull’s eye? This depends on the scale. At one extreme
there is the pedantic crystallographer who uses his tiny
ruler, counting small deviations as a failure. At the other
extreme there is the generous theoretician who celebrates
a globular blob as a big success. Hence, the statement “the
protein folding problem is solved” holds a different
meaning to different people.
To make progress, processes of self-control, common lan-
guage and cooperation are required. For quite some time
structural biologists were aware of this, but there was no
solution. We do not know the date nor the exact circum-
stances of the CASP inspiration, but we do know that it
was perceived by John Moult. To have an idea and to
make it happen are quite different issues, however.
First of all, CASP needs suitable targets. The structures
must be unknown to predictors, but available for evalua-
tion. This unique constellation is found in X-ray and
NMR laboratories, but the people there are not particu-
larly inclined to talk about their unfinished projects and
they usually do not see any advantage in a commitment to
release their structures before they might be published.
Secondly, CASP needs predictors. These are serious scien-
tists. They work on frightening formulae to compute com-
plicated structures — and they know quite well how
difficult it is to predict a protein fold. Why should they risk
a likely failure? Finally, CASP needs assessors. An assessor
cannot also be a predictor and her/his duty is to judge and
criticize their colleagues work in public, a rather unpleas-
ant and dangerous job. This sounds difficult enough, but
on top of that CASP has to be organized as a worldwide
experiment, and its ideas, results and conclusions have to
be communicated to the interested community as well as
to the indifferent funding agency. To make CASP happen
was not a small feat, but John Moult did it [1].
The CASP experiment is now a recurrent phenomenon in
computational structural biology that controls the clock
and mind of many workers in the field. The CASP cycle
spans two years. The first year is used for recovery from
the previous cycle, followed by a period of new inventions
and developments. This quiet and often leisurely time
ends when the prediction season starts in the second year,
with the first targets appearing in spring.
As a general rule, activity on early targets is low. Possible
explanations are that predictors are taken by surprise not
having their gear ready, or that the lifetime of early targets
is unusually short. In any case, the major flocks appear in
summer with peaks in July and August, triggering a flood
of submissions with a maximum peak during the closing
days in early September.
Then follows the assessment, an uneasy period for predic-
tors with tensions running high. This is a time of doubts,
rumors, and self-made CASP winners. Rumors cease when
the assessors choose the 18 groups whose predictions are
considered to be the most successful or whose techniques
seem to be the most interesting. The cycle ends with the
meeting in December where assessors summarize their
conclusions in Asilomar’s wooden chapel, along with the
chosen ones who present their results and reflect on the
themes ‘What went right?’ and ‘What went wrong?’
So much for the suffering, but what about happiness and
fun in CASP3? There was, in fact, a lot — not counting
the luring Asilomar beach and neglecting the bar and free
beverages. Assessors and predictors presented exciting
results with the intensity of emotions depending on your
profession. We skip heavy numbers and minute details
here to summarize a few essential points.
The 43 targets split into two groups. The first group con-
tains targets that have detectable sequence homology to
proteins in the Brookhaven Protein Data Bank (PDB).
These are the targets for comparative modeling. For the
predictor the goal here is to align the target sequence to
the template and to model loops and sidechains. The
second group consists of those targets that have no
detectable sequence homolog in the PDB. For these
targets there might be a related fold in the PDB, but who
knows? The goal of the fold recognition teams is to spot
such folds and to align the target sequence in a reasonable
way. At the same time this second group of targets is the
playground for those who start ab initio.
There were 20 targets comprising 22 domains in the fold
recognition/ab initio categories and as it turned out only two
of these were new folds. One has to take this statement
with a grain of salt, as structural similarity is a tricky thing
that is hard to nail down quantitatively. But these two folds
really are new. The remaining 20 folds span a range of simi-
larity with roughly half of them having clear structural rela-
tionships to something in the PDB and the other half
comprising borderline cases.
This result is in itself quite interesting, and even more so
in the light of structural genomics. Most folds were
known but we didn’t know they were. One highlight of
CASP3 was that the fold recognition teams and threaders
did know quite often. Taken together they correctly
assigned 11 domains to a close structural homolog in the
PDB and another four for the borderline cases. They
failed in five of the difficult cases and they missed one
domain in a multidomain protein that had clear structural
homology to a fold in the PDB. The quality of results are
not spread evenly, but there were at least six groups that
did quite well. This soothes the troubled soul of the fold
recognizer who often has to endure the evil mutter that
all he does is align sequences in a complicated way. In
fact, for most of these CASP3 targets there was nothing to
gain on the sequence level.
How did things fare in the ab initio section? The practi-
tioners in this corner frequently start at some unreasonable
point in conformation space, and with the help of clever
rules they try to get close to the native conformation. They
often hear whispers that their results are no better than
random. Not so in CASP3. There was no doubt that the
fold had moved in the right direction in several cases and,
most importantly, some of the predictions were better than
the best template found in the PDB.
This leaves us with comparative modeling. Don’t change
the template was the lesson from CASP1 and CASP2, and
this is still good advice. Another key to success is an
appropriate alignment technique, which is the domain of
threading. No big surprise then that an uprooted threader
had to confess in the comparative modeling session.
To summarize, quite a lot went right in this third CASP
experiment. But does it have an impact on structural
biology outside the circle of predictors? Yes it has — and
its impact is quite significant. Here is just one example.
Structural genomics is determined to spend a billion
dollars to solve the 10,000 protein structures that are
thought to be required to cover fold space. The project
will benefit from some coordinated action.
Fold recognition is the method of choice to avoid redun-
dant structure determination. These techniques are not
yet perfect, but the more successful variants are able to
spot related folds with a success rate of better than 60%.
This number is an average; in fact, the answers are quite
reliable in some cases and less reliable in others. Hence,
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before hunting for a new fold consult a threader. If he can
help just 10% of the time this might save you a hundred
million dollars in the long run.
Then finally, is the protein folding problem solved? The
lucky theoretician trumpets an overblown yes, but the
grumpy crystallographer does not care to listen. And, by
the way John, thanks for the rides on your roller coaster!
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